Change Healthcare
Get twice-weekly insights on the biggest stories shaping cardiology.
You might also like
Cardiology Pharmaceuticals January 5, 2026
Aficamten Approved, Enter a New HCM Contender January 5, 2026
After years of dedicated research and careful science, Cytokinetics’ aficamten (Myqorzo) is officially FDA approved for obstructive hypertrophic cardiomyopathy, marking the company’s first-ever regulatory approval and ending BMS mavacamten’s reign as the only oHCM treatment. The FDA’s decision stemmed from the SEQUOIA-HCM trial, which demonstrated aficamten’s efficacy over 24 weeks in symptomatic obstructive HCM patients […]
Cardiology Business December 18, 2025
Philips Acquires SpectraWAVE, Making Azurion Even Better December 18, 2025
After taking a two and a half year break since its last acquisition, Philips acquired SpectraWAVE for its HyperVue and X1-FFR technologies in a bid to extend its intravascular imaging lead. At the center of this acquisition, Philips’ Azurion is an image-guided therapy platform that already serves 7.6M patients annually. It combines coronary imaging and […]
Population Health December 14, 2025
Masters Athletes’ Hearts are Different, Especially When Imaged December 14, 2025
A recent JACC state-of-the-art review suggests that older athletes might face some unique cardiovascular changes, and although medical imaging can help identify their risk, the results need to be carefully interpreted. To better understand these patients, researchers looked at how physicians interpret multiple cardiac imaging modalities for masters athletes especially for changes in heart structure […]